Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for BillionToOne, Inc. (BLLN : NSDQ)

• Company Description    BillionToOne Inc. is a molecular diagnostics company. BillionToOne Inc. is based in headquartered in Menlo Park, California. Number of Employees: 713

• Price / Volume Information    Yesterday's Closing Price: $88.45 Daily Weekly Monthly 20 Day Moving Average: 298,151 shares Shares Outstanding: 45.97 (millions) Market Capitalization: $4,065.68 (millions) Beta: 52 Week High: $138.70 52 Week Low: $61.96 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 26.00% 29.13% 12 Week -8.67% -3.89% Year To Date 8.08% 11.81%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1035 O`BRIEN DRIVE - MENLO PARK,CA 94025 USA ph: 650-460-2551 fax: - ir@billiontoone.com http://www.billiontoone.com

• General Corporate Information    Officers Oguzhan Atay - Chief Executive Officer and Director Ross Taylor - Chief Financial Officer David Tsao - Chief Technology Officer and Director Thomas Bremner - Director Firat Ileri - Director Peer Information BillionToOne, Inc. (BJCT) BillionToOne, Inc. (CADMQ) BillionToOne, Inc. (APNO) BillionToOne, Inc. (UPDC) BillionToOne, Inc. (IMTIQ) BillionToOne, Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 090168105 SIC: 8071 Fiscal Year Fiscal Year End: December Last Reported Quarter: 12/01/25 Next Expected EPS Date: 06/03/26 Share - Related Items Shares Outstanding: 45.97 Most Recent Split Date: (:1) Beta: Market Capitalization: $4,065.68 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.06 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.42 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 06/03/26

• Fundamental Ratios P/E Current FY Estimate: 211.86 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 8.44 Price/Cash Flow: 273.27 Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: 10.00% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: 15.00% ROE 03/31/26 - - 12/31/25 - - 09/30/25 - - ROA 03/31/26 - - 12/31/25 - - 09/30/25 - - Current Ratio 03/31/26 - - 12/31/25 - 11.69 09/30/25 - 6.17 Quick Ratio 03/31/26 - - 12/31/25 - 11.32 09/30/25 - 5.75 Operating Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Net Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Pre-Tax Margin 03/31/26 - - 12/31/25 - 2.54 09/30/25 - - Book Value 03/31/26 - - 12/31/25 - 10.48 09/30/25 - -21.43 Inventory Turnover 03/31/26 - - 12/31/25 - 5.53 09/30/25 - - Debt-to-Equity 03/31/26 - - 12/31/25 - 0.12 09/30/25 - - Debt-to-Capital 03/31/26 - - 12/31/25 - 10.71 09/30/25 - -

Powered by Zacks Investment Research ©